journal article·2024-01Open access

Simultaneously Modulating HIF-1α and HIF-2α and Optimizing Macrophage Polarization through the Biomimetic Gene Vector toward the Treatment of Osteoarthritis

Boyuan Zheng, Yiwan Shi, Lei Xiao, Bowei Li, Zihang Chen, Jing Zhao, Shaoping Li, Huige Hou, Jieruo Li, Xianlong Cai, Huajun Wang, Peng Wu, Xiaofei Zheng

Abstract

In osteoarthritis (OA), articular cartilage is continuously submerged in a hypoxic environment throughout life, and hypoxia-inducible factors (HIFs) play a crucial role in OA progression. Among the various HIF phenotypes, HIF-1α positively contributes to maintaining the stability of the articular cartilage matrix. In contrast, HIF-2α has a detrimental effect, leading to chondrocyte apoptosis and exacerbating inflammation. Notably, there is currently no simultaneous regulation of HIF-1α and HIF-2α for OA treatment. Thus, the biomimetic gene vector (MENP) was developed for co-delivery of siHIF-2α and Mg 2+ to the inflamed regions in OA joints, comprising an inner core consisting of siHIF-2α and Mg 2+ and an outer M2 macrophage membrane. In vitro and in vivo studies demonstrate that MENP effectively targets inflamed areas, efficiently silences HIF-2α, and facilitates HIF-1α-mediated cartilage restoration through Mg 2+ . Furthermore, it indirectly promotes the polarization of macrophages toward an anti-inflammatory M2 phenotype through its action on inflamed synoviocytes. Overall, MENP is an efficient biomimetic vehicle for alleviating inflammation and promoting cartilage repair, representing an appealing approach for OA treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Bone and Joint Diseases · Bone Metabolism and Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Sports Medicine, The First Affiliated Hospital, Guangdong Provincial Key Laboratory of Speed Capability, The Guangzhou Key Laboratory of Precision Orthopedics and Regenerative Medicine, State Key Laboratory of Frigid Zone Cardiovascular Diseases, Jinan University, 510630 Guangzhou, China.

Department of Psychology, Li Ka Shing Faculty of Medicine, State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR, China.

Joint Laboratory of Chinese Herbal Glycoengineering and Testing Technology, University of Macau and National Glycoengineering Research Center, Macao, China.

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, Department of Pharmaceutical Sciences, Faculty of Health Sciences, University of Macau, Macao, China.

Department of Orthopedics, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, 200072 Shanghai, China.

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province · Clinical Frontier Technology Program of the First Affiliated Hospital of Jinan University · Science and Technology Projects in Guangzhou · the Fundamental Research Funds for the Central Universities · uangdong Medical Science and Technology Research Fund Project · Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutesof China

References (52)

Show source-provided references
1. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: A review. JAMA. 2021;325(6):568–578.10.1001/jama.2020.22171 ↗
2. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745–1759.10.1016/S0140-6736(19)30417-9 ↗
3. Marita C, Emma S, Damian H, Sandra N, Ilana A, Marlene F, Lisa B, Sean W, Francis G, Catherine LH, et al. The global burden of hip and knee osteoarthritis: Estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323.10.1136/annrheumdis-2013-204763 ↗
4. Zheng L, Zhang Z, Sheng P, Mobasheri A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res Rev. 2021;66: Article 101249.10.1016/j.arr.2020.101249 ↗
5. Choi W-S, Lee G, Song W-H, Koh J-T, Yang J, Kwak J-S, Kim H-E, Kim SK, Son Y-O, Nam H, et al. The CH25H–CYP7B1–RORα axis of cholesterol metabolism regulates osteoarthritis. Nature. 2019;566(7743):254–258.10.1038/s41586-019-0920-1 ↗
6. 10.1126/sciadv.abo786810.1126/sciadv.abo7868 ↗
7. Thoms BL, Dudek KA, Lafont JE, Murphy CL. Hypoxia promotes the production and inhibits the destruction of human articular cartilage. Arthritis Rheum. 2013;65(5):1302–1312.10.1002/art.37867 ↗
8. Fernández-Torres J, Martínez-Nava GA, Gutiérrez-Ruíz MC, Gómez-Quiroz LE, Gutiérrez M. Role of HIF-1α signaling pathway in osteoarthritis: A systematic review. Rev Bras Reumatol Engl Ed. 2017;57(2):162–173.
9. Bouaziz W, Sigaux J, Modrowski D, Devignes C-S, Funck-Brentano T, Richette P, Ea H-K, Provot S, Cohen-Solal M, Haÿ E. Interaction of HIF1α and β-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice. Proc Natl Acad Sci U S A. 2016;113(19):5453–5458.10.1073/pnas.1514854113 ↗
10. Yang S, Kim J, Ryu J-H, Oh H, Chun C-H, Kim BJ, Min BH, Chun J-S. Hypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med. 2010;16(6):687–693.10.1038/nm.2153 ↗
11. Zhang X-A, Kong H. Mechanism of HIFs in osteoarthritis. Front Immunol. 2023;14:1168799.10.3389/fimmu.2023.1168799 ↗
12. Eggleston AK, Eccleston A, Marte B, Lupp C. Regulatory RNA. Nature. 2012;482(7385):321–321.10.1038/482321a ↗
13. 10.1146/annurev-med-012017-04333210.1146/annurev-med-012017-043332 ↗
14. 10.1016/j.trsl.2019.07.00210.1016/j.trsl.2019.07.002 ↗
15. Yan H, Duan X, Pan H, Holguin N, Rai MF, Akk A,Springer LE, Wickline SA, Sandell LJ, Pham CTN. Suppression of NF-κB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury. Proc Natl Acad Sci U S A. 2016;113(41):E6199–E6208.
16. Gong Y, Li S-J, Liu R, Zhan J-F, Tan C, Fang Y-F, Chen Y, Yu B. Inhibition of YAP with siRNA prevents cartilage degradation and ameliorates osteoarthritis development. J Mol Med. 2019;97(1):103–114.10.1007/s00109-018-1705-y ↗
17. Hoshi H, Akagi R, Yamaguchi S, Muramatsu Y, Akatsu Y, Yamamoto Y, Sasaki T, Takahashi K, Sasho T. Effect of inhibiting MMP13 and ADAMTS5 by intra-articular injection of small interfering RNA in a surgically induced osteoarthritis model of mice. Cell Tissue Res. 2017;368(2):379–387.10.1007/s00441-016-2563-y ↗
18. Pi Y, Zhang X, Shao Z, Zhao F, Hu X, Ao Y. Intra-articular delivery of anti-Hif-2α siRNA by chondrocyte-homing nanoparticles to prevent cartilage degeneration in arthritic mice. Gene Ther. 2015;22(6):439–448.10.1038/gt.2015.16 ↗
19. Lopes J, Lopes D, Pereira-Silva M, Peixoto D, Veiga F, Hamblin MR, Conde J, Corbo C, Zare EN, Ashrafizadeh M, et al. Macrophage cell membrane-cloaked nanoplatforms for biomedical applications. Small Methods. 2022;6(8):2200289.10.1002/smtd.202200289 ↗
20. 10.1080/1061186X.2022.207142610.1080/1061186X.2022.2071426 ↗
21. Cai B, Lin D, Li Y, Wang L, Xie J, Dai T, Liu F, Tang M, Tian L, Yuan Y, et al. N2-polarized neutrophils guide bone mesenchymal stem cell recruitment and initiate bone regeneration: A missing piece of the bone regeneration puzzle. Adv Sci. 2021;8(19):2100584.10.1002/advs.202100584 ↗
22. Tan S, Wu T, Zhang D, Zhang Z. Cell or cell membrane-based drug delivery systems. Theranostics. 2015;5(8):863–881.10.7150/thno.11852 ↗
23. Li R, He Y, Zhu Y, Jiang L, Zhang S, Qin J, Wu Q, Dai W, Shen S, Pang Z, et al. Route to rheumatoid arthritis by macrophage-derived microvesicle-coated nanoparticles. Nano Lett. 2019;19(1):124–134.10.1021/acs.nanolett.8b03439 ↗
24. Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, Li Y. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano. 2016;10(8):7738–7748.10.1021/acsnano.6b03148 ↗
25. Zhou K, Yang C, Shi K, Liu Y, Hu D, He X, Yang Y, Chu B, Peng J, Zhou Z, et al. Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage. Biomaterials. 2023;295: Article 122036.10.1016/j.biomaterials.2023.122036 ↗
26. Wang Y, Zhang K, Li T, Maruf A, Qin X, Luo L, Zhong Y, Qiu J, McGinty S, Pontrelli G, et al. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics. 2021;11(1):164–180.10.7150/thno.47841 ↗
27. Sezer N, Evis Z, Kayhan SM, Tahmasebifar A, Koç M. Review of magnesium-based biomaterials and their applications. J Magn Alloys. 2018;6(1):23–43.10.1016/j.jma.2018.02.003 ↗
28. Sun Y, Wu H, Wang W, Zan R, Peng H, Zhang S, Zhang X. Translational status of biomedical Mg devices in China. Bioact Mater. 2019;4:358–365.
29. 10.1016/j.nutres.2021.03.00210.1016/j.nutres.2021.03.002 ↗
30. Gao C, Dai W, Wang X, Zhang L, Wang Y, Huang Y, Yuan Z, Zhang X, Yu Y, Yang X, et al. Magnesium gradient-based hierarchical scaffold for dual-lineage regeneration of osteochondral defect. Adv Funct Mater. 2023;33(43):2304829.10.1002/adfm.202304829 ↗
31. Yao H, Xu JK, Zheng NY, Wang JL, Mok SW, Lee YW, Shi L, Wang JY, Yue J, Yung SH, et al. Intra-articular injection of magnesium chloride attenuates osteoarthritis progression in rats. Osteoarthr Cartil. 2019;27(12):1811–1821.10.1016/j.joca.2019.08.007 ↗
32. 10.1016/j.bioactmat.2020.10.01610.1016/j.bioactmat.2020.10.016 ↗
33. Wu P, Zhang H, Yin Y, Sun M, Mao S, Chen H, Deng Y, Chen S, Li S, Sun B. Engineered EGCG-containing biomimetic nanoassemblies as effective delivery platform for enhanced cancer therapy. Adv Sci. 2022;9(15):2105894.10.1002/advs.202105894 ↗
34. 10.1002/anie.20191497010.1002/anie.201914970 ↗
35. Zhao Z, Pan DC, Qi QM, Kim J, Kapate N, Sun T, Shields CW IV, Wang LL-W, Wu D, Kwon CJ, et al. Engineering of living cells with polyphenol-functionalized biologically active nanocomplexes. Adv Mater. 2020;32(49):2003492.10.1002/adma.202003492 ↗
36. 10.1021/acscentsci.8b0036310.1021/acscentsci.8b00363 ↗
37. 10.1021/acsami.9b1722110.1021/acsami.9b17221 ↗
38. Zhou K, He S, Yu H, Pei F, Zhou Z. Inhibition of syndecan-4 reduces cartilage degradation in murine models of osteoarthritis through the downregulation of HIF-2α by miR-96-5p. Lab Investig. 2021;101(8):1060–1070.10.1038/s41374-021-00595-5 ↗
39. Zhao J, Ouyang Q, Hu Z, Huang Q, Wu J, Wang R, Yang M. A protocol for the culture and isolation of murine synovial fibroblasts. Biomed Rep. 2016;5(2):171–175.10.3892/br.2016.708 ↗
40. Deng Y, Zhou Y, Liang Q, Ge C, Yang J, Shan B, Liu Y, Zhou X, Yin L. Inflammation-instructed hierarchical delivery of IL-4/miR-21 orchestrates osteoimmune microenvironment toward the treatment of rheumatoid arthritis. Adv Funct Mater. 2021;31(33):2101033.10.1002/adfm.202101033 ↗
41. 10.1038/nrrheum.2014.4610.1038/nrrheum.2014.46 ↗
42. 10.1073/pnas.171426711410.1073/pnas.1714267114 ↗
43. Uchida H, Miyata K, Oba M, Ishii T, Suma T, Itaka K, Nishiyama N, Kataoka K. Odd-even effect of repeating aminoethylene units in the side chain of N-substituted polyaspartamides on gene transfection profiles. J Am Chem Soc. 2011;133(39):15524–15532.10.1021/ja204466y ↗
44. Kovács B, Vajda E, Nagy EE. Regulatory effects and interactions of the Wnt and OPG-RANKL-RANK signaling at the bone-cartilage interface in osteoarthritis. Int J Mol Sci. 2019;20(18):4653.10.3390/ijms20184653 ↗
45. Wang P, Zhu P, Liu R, Meng Q, Li S. Baicalin promotes extracellular matrix synthesis in chondrocytes via the activation of hypoxia-inducible factor-1α. Exp Ther Med. 2020;20(6):226.10.3892/etm.2020.9356 ↗
46. Zhang F-J, Luo W, Lei G-H. Role of HIF-1α and HIF-2α in osteoarthritis. Joint Bone Spine. 2015;82(3):144–147.10.1016/j.jbspin.2014.10.003 ↗
47. Stegen S, Laperre K, Eelen G, Rinaldi G, Fraisl P, Torrekens S, Van Looveren R, Loopmans S, Bultynck G, Vinckier S, et al. HIF-1α metabolically controls collagen synthesis and modification in chondrocytes. Nature. 2019;565(7740):511–515.10.1038/s41586-019-0874-3 ↗
48. Deng C, Zhang Q, He P, Zhou B, He K, Sun X, Lei G, Gong T, Zhang Z. Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis. Nat Commun. 2021;12(1):2174.10.1038/s41467-021-22454-z ↗
49. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6(11):625–635.10.1038/nrrheum.2010.159 ↗
50. Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther. 2006;8(6):R187.10.1186/ar2099 ↗
51. Qiao W, Wong KHM, Shen J, Wang W, Wu J, Li J, Lin Z,Chen Z, Matinlinna JP, Zheng Y, et al. TRPM7 kinase-mediated immunomodulation in macrophage plays a central role in magnesium ion-induced bone regeneration. Nat Commun. 2021;12(1):2885.10.1038/s41467-021-23005-2 ↗
52. Bessa-Gonçalves M, Ribeiro-Machado C, Costa M, Ribeiro CC,Barbosa JN, Barbosa MA, Santos SG. Magnesium incorporation in fibrinogen scaffolds promotes macrophage polarization towards M2 phenotype. Acta Biomater. 2023;155:667–683.10.1016/j.actbio.2022.10.046 ↗